Clinical Trial Update: Etanercept SFP in RA Patients [Phase 3]

View source ↗

Summary

The Phase 3 clinical trial of Etanercept SFP for rheumatoid arthritis has completed; the update notes status but does not report results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Etanercept SFP (etanercept)

Snippet

Sponsor: Amgen | Conditions: Rheumatoid Arthritis | Phase 3 | Status: COMPLETED